Pioglitazone Intermediate112529-15-4/105355-26-8, China Pioglitazone Intermediate112529-15-4/105355-26-8 Supplier

Pioglitazone Intermediate112529-15-4/105355-26-8 - 112529-15-4/105355-26-8/105355-25-7

Pioglitazone Intermediate112529-15-4/105355-26-8 For Sale, Most Competitive Price, Fast Delivery, Custom Service, Wholesale Pioglitazone Intermediate112529-15-4/105355-26-8, Made in China, High Quality Products!, China Pioglitazone Intermediate, Pharmaceutical intermediates Supplier, Manufacturer.

Pioglitazone Intermediate112529-15-4/105355-26-8/105355-25-7
(1) Product Name : Pioglitazone HCL
CAS No. :112529-15-4
(2) Product Name : 5-{4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl}-2-imino-4-thiazolidinone
CAS No. :105355-26-8
(3) Product Name : Methyl-2-bromo-3-[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]propionate
CAS No. :105355-25-7

Get Quote

Cangzhou Senary Chemical Science-tech Co., Ltd

Address: 168 Jinde Road, Cangzhou City, Hebei Province, China , Cangzhou , Hebei, China, 061000
Tel: 0086-317-3563899
Found in 2003, Cangzhou Senary Chemical Science-tech Co., Ltd strives to be a leading manufacturer of Active Pharmaceutical Ingredients and Pharmaceutical intermediates with unique, widely-used, and innovative products with top quality. Senary focus on researching and manufacturing Anti-diabetic, Anti-alzheimer API and intermediates leading products include Glimepiride, Donepezil, Piglitazone Hcl and Rivastigmine tartrate. We could offer both the API and their series intermediates. Depending on international advanced production technology and excellent production quality, Senary has become a global manufacturing supplier and the biggest production base. Especially Glimepiride intermediates we have already share around 70% of global market. What Senary鈥檚 goal is to become the most professional and most competitive pharmaceutical enterprises in these two areas. We will continue to explore new technologies and new products. Our goal is to delivery top quality products and best services to match customer鈥檚 specific needs on time in world pharmaceutical market.